BARBALISCIA, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 858
AS - Asia 151
EU - Europa 79
AF - Africa 4
SA - Sud America 2
OC - Oceania 1
Totale 1.095
Nazione #
US - Stati Uniti d'America 854
KR - Corea 74
SG - Singapore 34
IE - Irlanda 21
CN - Cina 19
PK - Pakistan 13
DE - Germania 12
IT - Italia 12
RU - Federazione Russa 10
GB - Regno Unito 8
BD - Bangladesh 6
UA - Ucraina 6
SE - Svezia 5
CA - Canada 4
ET - Etiopia 3
CL - Cile 2
FR - Francia 2
HK - Hong Kong 2
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
IN - India 1
JP - Giappone 1
RS - Serbia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.095
Città #
Wilmington 237
Houston 156
Woodbridge 133
Chandler 86
Fairfield 37
Singapore 32
Ashburn 28
Dublin 20
Seattle 16
Ann Arbor 15
Medford 15
Santa Clara 9
Beijing 7
Cambridge 7
Dearborn 7
Lawrence 7
Creede 6
New York 6
Rome 6
Gainesville 5
San Diego 5
Faisalabad 4
Lahore 4
Menlo Park 4
Addis Ababa 3
Karachi 3
Milan 3
Palo Alto 3
Brantford 2
Hong Kong 2
Islamabad 2
Jacksonville 2
Nuremberg 2
The Dalles 2
Wuhan 2
Zhengzhou 2
Augusta 1
Belgrade 1
Boardman 1
Brno 1
Burlington 1
Caserta 1
Chiswick 1
Fremont 1
Guangzhou 1
Hangzhou 1
Los Angeles 1
Midrand 1
Moscow 1
Mountain View 1
Munich 1
Nanjing 1
Nürnberg 1
Ottawa 1
Qingdao 1
Redwood City 1
Rochester 1
San Mateo 1
Seoul 1
Shanghai 1
Slough 1
Taipei 1
Tokyo 1
Toronto 1
Washington 1
Totale 909
Nome #
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study 365
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 362
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 155
Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019 76
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b 61
Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study 61
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 47
Totale 1.127
Categoria #
all - tutte 3.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.354


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020191 0 0 0 0 21 26 23 19 33 27 21 21
2020/2021172 18 21 16 20 17 21 22 19 4 6 4 4
2021/202294 0 1 0 2 1 13 9 6 28 2 4 28
2022/2023155 15 21 16 26 11 30 6 17 6 1 5 1
2023/202453 2 1 2 2 13 12 0 4 2 0 3 12
2024/202578 8 34 14 18 4 0 0 0 0 0 0 0
Totale 1.127